Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients


PURPOSE The measurement of serum human epidermal growth factor receptor 2 (HER2) extracellular domain levels is a well-established method for evaluating whether a metastatic HER2-positive breast cancer patient will respond to HER2-targeted treatment. However, little is known about the value of serum HER2 for detecting disease relapse following curative… (More)
DOI: 10.4048/jbc.2014.17.1.33


9 Figures and Tables